Clinical Trial Update: R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing R±CEOP90 versus R±CEOP75 in newly diagnosed young patients with medium/high-risk diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: FENG Ji-feng | Conditions: Diffuse Large B-cell Lymphoma | Phase 3 | Status: UNKNOWN